Bio-Techne
TECH
#1479
Rank
A$18.33 B
Marketcap
$115.39
Share price
-0.50%
Change (1 day)
27.67%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2023 (TTM): $2.36

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is $2.38. In 2022 the company made an earnings per share (EPS) of $2.54 an increase over its 2021 EPS that were of $2.04.

EPS history for Bio-Techne from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.36-6.99%
2022$2.5424.35%
2021$2.0417.98%
2020$1.73-10.94%
2019$1.94101.57%
2018$0.96-17.53%
2017$1.1739.37%
2016$0.84-17.23%
2015$1.01-14.97%
2014$1.191.29%
2013$1.183.68%
2012$1.14-1.97%
2011$1.161.67%
2010$1.147.14%
2009$1.06-1.06%
2008$1.0719.41%
2007$0.9019.1%
2006$0.7610.56%
2005$0.6829.5%
2004$0.5313.05%
2003$0.4768.43%
2002$0.28-17.05%
2001$0.3317.33%
2000$0.2848.51%
1999$0.1923.17%
1998$0.1613.89%
1997$0.1442.57%
1996$0.09589

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$23.30 877.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$8.69-464.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.43 253.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$12.18 410.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.21-7.38%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$12.99 444.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.43-159.87%๐Ÿ‡บ๐Ÿ‡ธ USA